Breast Implants and Reconstructive Devices | Market Insights | US | 2020
The cancellation or postponement of elective procedures, including breast augmentations and reconstructions, due to the COVID-19 pandemic will have a moderately negative impact on the US market for breast implants and reconstructive devices in the short term, compounding the recent market decline due to the association of BIA-ALCL with macrotextured silicone breast implants. However, the market will return to growth, supported by continued patient demand for augmentation and reconstruction procedures, innovative technologies that improve the ease of implant placement, and efforts by companies to address concerns regarding product safety.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for breast implants and reconstructive devices in the US across a 10-year period.
